The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Top Cited Papers
- 16 March 2010
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 17 (3), 225-234
- https://doi.org/10.1016/j.ccr.2010.01.020
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative NeoplasmsThe New England Journal of Medicine, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeThe New England Journal of Medicine, 2009
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- IDH1andIDH2Mutations in GliomasThe New England Journal of Medicine, 2009
- Analytical strategies for LC–MS-based targeted metabolomicsJournal of Chromatography B, 2008
- Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approachNature Protocols, 2008
- Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesisProceedings of the National Academy of Sciences of the United States of America, 2007
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Crystal Structure of Porcine Mitochondrial NADP+-dependent Isocitrate Dehydrogenase Complexed with Mn2+ and IsocitrateOnline Journal of Public Health Informatics, 2002